To investigate the efficacy of USP7 as a potential target for cancer reversion in colon cancer organoids, we conducted USP7 knockdown experiments using the inhibitor P22077 in colon cancer organoids previously used in the process of network reconstruction. The gene discussed is USP7; the disease is malignant colon neoplasm.